Key result
S3 presence is linked to ~10-fold higher odds of LGE-detected myocardial fibrosis in HCM patients.
Why the study?
Extra heart sounds S3 and S4 in HCM patients may be associated with myocardial fibrosis affecting left ventricular compliance, but their relationship is unclear.
Does the presence of a 3rd or 4th heart sound correlate with myocardial fibrosis assessed by LGE-MRI in patients with hypertrophic cardiomyopathy?
Observational (n=53)
No
Does the presence of a 3rd or 4th heart sound correlate with myocardial fibrosis assessed by LGE-MRI in patients with hypertrophic cardiomyopathy?
Odds Ratio: 10.4 (95% CI 1.1–99.9)
Absolute Event Rate: 86% vs 33%
p-value: p=0.04
The presence of a third heart sound (S3) is highly specific for detecting myocardial fibrosis on MRI in asymptomatic patients with hypertrophic cardiomyopathy, whereas a fourth heart sound (S4) is not.
S3 was associated with LGE fibrosis in asymptomatic HCM; leaves open whether auscultation refines noninvasive risk stratification.
BACKGROUND: The 4th heart sound (S4) is commonly heard in patients with hypertrophic cardiomyopathy (HCM). The 3rd heart sound (S3) is also audible in HCM patients regardless of the presence or absence of heart failure. These extra heart sounds may be associated with myocardial fibrosis because myocardial fibrosis has been suggested to affect left ventricular compliance. METHODS AND RESULTS: The present retrospective study evaluated 53 consecutive HCM patients with sinus rhythm who had no symptoms of heart failure and underwent an initial assessment including phonocardiography, echocardiography, and late gadolinium enhancement (LGE) magnetic resonance imaging (MRI). S3 was detected on phonocardiography in 13% of all patients, and S4 was recorded in 75% of patients. Patients with S3 had a higher incidence of LGE and larger LGE volumes (86% and 11.5±2.4 g/cm, respectively) than patients without S3 (33% and 2.5±0.8 g/cm, respectively; P=0.02 and P=0.002). The presence of S4 was not associated with MRI findings, including the incidence of LGE and LGE volume. The diagnostic value of S3 for the detection of LGE was highly specific (97%), with a low sensitivity (29%). CONCLUSIONS: Myocardial fibrosis, as assessed by LGE, was associated with S3 but not with S4 in patients with HCM. These results may contribute to the risk stratification of patients with HCM.
No takes yet. Share an insight, caveat, or question.
Sato et al. (2017) conducted an observational in Hypertrophic Cardiomyopathy (n=53). Third heart sound (S3) vs. Absence of third heart sound was evaluated on Presence of late gadolinium enhancement (LGE) on MRI (OR 10.4, 95% CI 1.1-99.9, p=0.04). The presence of a third heart sound (S3) was independently associated with myocardial fibrosis, as assessed by late gadolinium enhancement on MRI, in patients with hypertrophic cardiomyopathy (OR 10.4).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: